Form D · Biotechnology
Vatrix Medical Inc
Eden Prairie, MN · CIK 0001409500
Offering snapshot reported Jan 7, 2010 · SEC filing
- Reported sold
- $170K Offering amount: $200K
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 10, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 7, 2010 | Initial | $170,000 | No comparison | 8 | SEC filing |
| Jan 7, 2010 | Initial | $60,000 | No comparison | 2 | SEC filing |
| Aug 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 04
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-107246
Source: Form D, filed Jan 7, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nancy J. Ness | Director, Executive |
| Raymond W. Ogle | Director |
| Matthew F. Ogle | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
7600 Executive Drive
Eden Prairie, MN, 55305
Eden Prairie, MN, 55305